Greater Cannabis Company IncOOTC GCAN Stock Report

The Greater Cannabis Co., Inc. focuses on cannabis related investment and development opportunities through its online retail store, GCC Superstore, direct equity investments, joint ventures, licensing agreements, or acquisitions. The company is headquartered in Baltimore, Maryland. The company went IPO on 2018-07-09. The firm conducts medical research, and is pursuing clinical trials, to develop cannabis-based treatments for various medical conditions and their symptoms with an initial focus on neuropsychiatric disorders. The firm develops cannabinoid therapeutics focused on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders and concentrate on cannabis related investment and development opportunities through direct equity investments, joint ventures, licensing agreements or acquisitions. Its delivery technologies use a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides for a needle-free, intra-oral systemic drug delivery.